Jim Cramer Recently Looked at These 25 Stocks
We're in critical short supply for all sorts of chips that are needed in the data center... It wasn't easy to forecast this boom, I admit, as recently as one year ago.
Aquestive Therapeutics Inc. (AQST)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 2,625,000 | $16,957,500 | 0.77% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 2,500,000 | $16,150,000 | 1.67% | |
| 3. | Millennium Management Israel Englander | 1,535,369 | $9,918,484 | +20% | 0% |
| 4. | Sio Capital Michael Castor | 993,095 | $6,415,394 | -34% | 1.01% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 970,939 | $6,272,266 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.81 | 5,000 | $4,050.00 | 59,532 | 2022-06-14 | Filing | |
| $0.96 | 91,743 | $88,073.28 | 193,702 | 2022-06-08 | Filing | |
| $0.96 | 45,871 | $44,036.16 | 882,871 | 2022-06-08 | Filing | |
| $0.96 | 2,293 | $2,201.28 | 54,532 | 2022-06-08 | Filing | |
| $0.96 | 13,761 | $13,210.56 | 38,761 | 2022-06-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.01 | 67,575 | $473,700.75 | 240,771 | 2025-10-15 | Filing | |
| $7.00 | 20,272 | $141,904.00 | 282,475 | 2025-10-15 | Filing | |
| $7.00 | 10,000 | $70,000.00 | 268,323 | 2025-10-15 | Filing | |
| $6.03 | 91,343 | $551,191.06 | 923,430 | 2025-09-26 | Filing | |
| $6.30 | 10,000 | $63,000.00 | 278,323 | 2025-09-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,810,958 | $63,378,789 | 100% | |
| 2. | 7,775,402 | $50,229,098 | 0% | |
| 3. | 6,250,000 | $40,375,000 | 0.4% | |
| 4. | 5,892,334 | $38,064,478 | 0% | |
| 5. | 2,462,778 | $15,909,546 | 0% |
News See All
Jim Cramer Recently Put These 18 Stocks Under a Microscope
“Look out, the year of magical investing may be drawing to a close. All this year, pretty much anybody who bought stocks connected to AI and the data center, well, you know, you made money.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q3 2025 Aquestive Therapeutics, Inc. Earnings Conference Call.
Jim Cramer’s Recent Takes on These 12 Stocks
“I'm talking about the extreme dichotomy between focusing on a body of wisened economists who are being pushed around by a president who wants to run the central bank and focusing on the free ruling...
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Aquestive Therapeutics Second Quarter 2025 Earnings Conference Call.
H.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA Approval
Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the best growth stocks to invest in for the next 5 years. Analysts at H.C.
15 Best Growth Stocks to Invest in for the Next 5 Years
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Aquestive Therapeutics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 Aquestive Therapeutics Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center